Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction-associated steatohepatitis.
Saved in:
| Title: | Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction-associated steatohepatitis. |
|---|---|
| Authors: | Yashaswini CN; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Medical Scientist Training Program, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Cogliati B; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Pathology, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo 05508-270, Brazil., Qin T; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., To T; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Williamson T; Department of Cell and Developmental Biology, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA.; Penn Cardiovascular Institute, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA.; Institute for Regenerative Medicine, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA., Papp TE; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA., Li K; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Medical Scientist Training Program, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Rasul R; Pharmanest Inc., Princeton, NJ 08540, USA., Chen L; Pharmanest Inc., Princeton, NJ 08540, USA., Lightstone A; Pharmanest Inc., Princeton, NJ 08540, USA., Aghajanian H; Department of Medicine, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA.; Capstan Therapeutics Inc., San Diego, CA 92121, USA., Parhiz H; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA., Wang S; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Rurik JG; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm 141 52, Sweden., Epstein JA; Department of Cell and Developmental Biology, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA.; Penn Cardiovascular Institute, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA.; Institute for Regenerative Medicine, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA.; Department of Medicine, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA., Friedman SL; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. |
| Source: | Science translational medicine [Sci Transl Med] 2026 Jan 21; Vol. 18 (833), pp. eadx0368. Date of Electronic Publication: 2026 Jan 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1946-6242 |
|---|---|
| DOI: | 10.1126/scitranslmed.adx0368 |
